LVAD therapy as a catalyst to heart failure remission and myocardial recovery.
Eman A HamadMirnela BykuSharon B LarsonFilio BilliaPublished in: Clinical cardiology (2023)
The management of chronic heart failure over the past decade has witnessed tremendous strides in medical optimization and device therapy including the use of left ventricular assist devices (LVAD). What we once thought of as irreversible damage to the myocardium is now demonstrating signs of reverse remodeling and recovery. Myocardial recovery on the structural, molecular, and hemodynamic level is necessary for sufficient recovery to withstand explant and achieve sustained recovery post-LVAD. Guideline-directed medical therapy and unloading have been shown to aid in recovery with the potential to successfully explant the LVAD. This review will summarize medical optimization, assessment for recovery, explant methodologies and outcomes post-recovery with explant of durable LVAD.
Keyphrases
- left ventricular
- heart failure
- healthcare
- left ventricular assist device
- type diabetes
- metabolic syndrome
- rheumatoid arthritis
- oxidative stress
- stem cells
- coronary artery disease
- systemic lupus erythematosus
- adipose tissue
- skeletal muscle
- gold nanoparticles
- insulin resistance
- percutaneous coronary intervention
- ionic liquid
- acute heart failure
- disease activity
- reduced graphene oxide